METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment

Despite the abnormal expression of 18S rRNA m6A methyltransferase METTL5 being reported in some types of human malignancies, but its effect on hepatocellular carcinoma (HCC) remains to be unclear. This study aims to elucidate the influences of METTL5 on the carcinogenesis and progression of HCC. Exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Peng, Jin-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318095/
https://www.ncbi.nlm.nih.gov/pubmed/37400463
http://dx.doi.org/10.1038/s41598-023-37807-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318095/
https://www.ncbi.nlm.nih.gov/pubmed/37400463
http://dx.doi.org/10.1038/s41598-023-37807-5

Ejemplares similares